ExploreWatchlistsPricing
  1. JP-listed companies
  2. TOWA PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. EBITDA

TOWA PHARMACEUTICAL CO.,LTD. (4553)

Market cap
¥219.2B
P/E ratio
11.8x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 202538,919+24.32%
Mar 31, 202431,306+58.31%
Mar 31, 202319,775-32.64%
Mar 31, 202229,358-0.81%
Mar 31, 202129,597+21.16%
Mar 31, 202024,428+0.49%
Mar 31, 201924,308+22.67%
Mar 31, 201819,816+33.45%
Mar 31, 201714,849-19.57%
Mar 31, 201618,463+9.71%
Mar 31, 201516,829

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat